[Value and limitations of indomethacin in the treatment of Bartter's syndrome].
D000328:Adult; D000450:Aldosterone / Q000097:blood; D000809:Angiotensins / Q000097:blood; D001477:Bartter Syndrome / Q000188:drug therapy*; D001835:Body Weight / Q000187:drug effects; D002199:Capillary Permeability / Q000187:drug effects; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy*; D007213:Indomethacin / Q000494:pharmacology / Q000627:therapeutic use*; D011188:Potassium / Q000378:metabolism; D012083:Renin / Q000097:blood; D012964:Sodium / Q000652:urine; D014882:Water-Electrolyte Balance / Q000187:drug effects
D000809:Angiotensins; D000450:Aldosterone; D012964:Sodium; D012083:Renin; D011188:Potassium; D007213:Indomethacin
Intérêt et limited de l'indométhacine dans le traitement du syndrome de Bartter.